Atlas Trials

Refractory Melanoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Melanoma

RecordFirmDate
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) (NCT05061017)Diwakar Davar2021-12-09
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801)M.D. Anderson Cancer Center2021-09-30
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04284774)National Cancer Institute (NCI)2020-10-13
Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases (NCT03175432)M.D. Anderson Cancer Center2017-06-15
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer (NCT02298959)National Cancer Institute (NCI)2015-04-08
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas (NCT02304458)National Cancer Institute (NCI)2015-03-30
Study of CP-675,206 in Refractory Melanoma (NCT00254579)AstraZeneca2005-12-01
Compassionate Use of Vidutolimod (NCT06063746)Regeneron Pharmaceuticals

Track Refractory Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.